Hyperfine (NASDAQ:HYPR – Free Report) had its price target trimmed by B. Riley from $1.20 to $1.00 in a report published on Thursday,Benzinga reports. The firm currently has a buy rating on the stock.
Several other brokerages also recently commented on HYPR. Lake Street Capital started coverage on Hyperfine in a research note on Monday, March 24th. They set a “buy” rating and a $1.50 target price on the stock. Wells Fargo & Company reduced their price objective on Hyperfine from $1.29 to $0.68 and set an “equal weight” rating for the company in a report on Wednesday.
View Our Latest Analysis on Hyperfine
Hyperfine Stock Up 3.6%
Hyperfine (NASDAQ:HYPR – Get Free Report) last posted its quarterly earnings results on Tuesday, May 13th. The company reported ($0.12) earnings per share for the quarter, hitting the consensus estimate of ($0.12). The company had revenue of $2.14 million for the quarter, compared to the consensus estimate of $2.82 million. Hyperfine had a negative return on equity of 57.54% and a negative net margin of 309.42%. As a group, equities analysts expect that Hyperfine will post -0.57 EPS for the current year.
Institutional Investors Weigh In On Hyperfine
Large investors have recently bought and sold shares of the business. Virtu Financial LLC bought a new position in shares of Hyperfine during the 4th quarter valued at $25,000. EP Wealth Advisors LLC bought a new position in shares of Hyperfine during the 1st quarter valued at $25,000. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Hyperfine by 64.3% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 82,008 shares of the company’s stock valued at $72,000 after buying an additional 32,093 shares during the period. AMH Equity Ltd bought a new position in shares of Hyperfine during the 1st quarter valued at $90,000. Finally, Renaissance Technologies LLC lifted its holdings in shares of Hyperfine by 32.9% during the 4th quarter. Renaissance Technologies LLC now owns 212,300 shares of the company’s stock valued at $187,000 after buying an additional 52,500 shares during the period. 15.03% of the stock is currently owned by institutional investors.
About Hyperfine
Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.
Featured Stories
- Five stocks we like better than Hyperfine
- Stock Sentiment Analysis: How it Works
- Top 4 ETFs for China Exposure After Tariff Relief
- Consumer Staples Stocks, Explained
- Build a Complete Bond Portfolio With These 4 ETFs
- Want to Profit on the Downtrend? Downtrends, Explained.
- MarketBeat Week in Review – 05/12 – 05/16
Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.